Due to the lack of a specific antibody for ubiquitinated HAX1, we defined ubiquitination levels based on TRIM23 localization and HAX1 protein levels, categorizing CRC tissues into four clinical-pathological types (Fig. 8D). This evidence concerns the gene TRIM23 and colorectal carcinoma.